<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:mayoclinic="http://mayoclinic.org"
>

<channel>
	<title>Research - Mayo Clinic News Network</title>
	<atom:link href="https://newsnetwork.mayoclinic.org/category/research/feed/" rel="self" type="application/rss+xml" />
	<link>https://newsnetwork.mayoclinic.org/category/research/</link>
	<description>News Resources</description>
	<lastBuildDate>Mon, 02 Feb 2026 16:07:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9</generator>
	<item>
		<title>Advancing&nbsp;epilepsy&nbsp;care:&nbsp;Mayo Clinic neurologist&nbsp;Dr. Gregory Worrell&nbsp;</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/advancing-epilepsy-care-mayo-clinic-neurologist-dr-gregory-worrell/</link>
		
		<dc:creator><![CDATA[Alison Satake]]></dc:creator>
		<pubDate>Fri, 30 Jan 2026 14:30:00 +0000</pubDate>
				<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Neurosciences]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Gregory Worrell]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409905</guid>

					<description><![CDATA[<p>Dr. Gregory Worrell&nbsp;shares&nbsp;how technological innovation is transforming the&nbsp;future of epilepsy&nbsp;care.&nbsp;</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/advancing-epilepsy-care-mayo-clinic-neurologist-dr-gregory-worrell/">Advancing&nbsp;epilepsy&nbsp;care:&nbsp;Mayo Clinic neurologist&nbsp;Dr. Gregory Worrell&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><strong>ROCHESTER, Minn.</strong>&amp;nbsp;—<strong>&amp;nbsp;</strong><a href="https://www.mayo.edu/research/faculty/worrell-gregory-a-m-d-ph-d/bio-00027235" target="_blank" rel="noreferrer noopener"><strong>Gregory Worrell, M.D., Ph.D.</strong></a>, is a&amp;nbsp;physician-scientist and&amp;nbsp;neurologist whose&amp;nbsp;research&amp;nbsp;focus is&amp;nbsp;<a href="https://www.mayoclinic.org/diseases-conditions/epilepsy/symptoms-causes/syc-20350093" target="_blank" rel="noreferrer noopener">epilepsy</a>&amp;nbsp;— a neurological disorder that causes seizures and affects more than&amp;nbsp;50 million people&amp;nbsp;worldwide. He is the William L. McKnight-3M Professor of Neuroscience at Mayo Clinic. Dr. Worrell&amp;nbsp;shares&amp;nbsp;how technological innovation is transforming the&amp;nbsp;future of epilepsy&amp;nbsp;care.&amp;nbsp;</p>



<p><strong><a href="https://youtu.be/vlN-PpDHfp8" target="_blank" rel="noreferrer noopener">Watch: Dr. Worrell discusses advancing epilepsy care</a></strong></p>



<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<div class="fluidEmbed"><iframe id="videoidhttpsyoutubevlNPpDHfp8"  title="Gregory Worrell, M.D., Ph.D. - The goal of BIONIC" width="500" height="281" src="https://www.youtube.com/embed/vlN-PpDHfp8?feature=oembed&amp;enablejsapi=1" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe></div>
</div></figure>



<p><strong>&amp;nbsp;Journalists: Broadcast-quality sound bites are available in the downloads at the end of the post. Please courtesy: "Mayo Clinic News Network." Name super/CG: Gregory Worrell, M.D., Ph.D./ Neurology /Mayo Clinic.</strong></p>



<p><br><strong>Why is epilepsy such a challenging condition to treat?</strong>&amp;nbsp;<br>Epilepsy affects people across the entire lifespan, from infancy through older adulthood. About one-third of patients continue to have seizures despite medication. Many also experience&amp;nbsp;disabling&amp;nbsp;comorbidities such as sleep disturbances, memory&amp;nbsp;problems&amp;nbsp;and mood disorders. Treating epilepsy effectively requires addressing all&amp;nbsp;of these challenges, not just seizures alone.&amp;nbsp;</p>



<p><strong>How does a team-based approach improve epilepsy care?</strong>&amp;nbsp;<br>Addressing epilepsy requires collaboration across many specialties, including&amp;nbsp;basic neuroscience, engineering,&amp;nbsp;neurology, neurosurgery,&amp;nbsp;neuroradiology&amp;nbsp;and psychiatry. By combining&amp;nbsp;expertise&amp;nbsp;and&amp;nbsp;leveraging&amp;nbsp;advances in biology, imaging,&amp;nbsp;engineering,&amp;nbsp;computing&amp;nbsp;and artificial intelligence, we can better meet the complex and unmet needs of patients.&amp;nbsp;&amp;nbsp;</p>



<p><strong>What is the&amp;nbsp;Bioelectronics Neuromodulation Innovation to Cure&amp;nbsp;(BIONIC)&amp;nbsp;Initiative, and why is it important for epilepsy care?</strong>&amp;nbsp;<br>The BIONIC&amp;nbsp;initiative is focused on changing the course of epilepsy therapy and diagnostics.&amp;nbsp;We're&amp;nbsp;in&amp;nbsp;a period of rapid technological acceleration — advances in artificial intelligence, neurotechnology, computing and connected devices. These tools allow us to deliver and adjust therapies in real time and to receive feedback from people with epilepsy as they go about their daily lives. This creates new opportunities to better understand epilepsy, create new&amp;nbsp;therapies&amp;nbsp;and improve patient care.&amp;nbsp;</p>



<p><strong>How do these technologies help people living with epilepsy day to day?</strong>&amp;nbsp;<br>Today, we can track seizures as well as common&amp;nbsp;epilepsy-related&amp;nbsp;comorbidities such as sleep problems, memory&amp;nbsp;issues&amp;nbsp;and mood disorders. Importantly, we can also intervene using neuromodulation&amp;nbsp;using&amp;nbsp;electrical&amp;nbsp;brain&amp;nbsp;stimulation,&amp;nbsp;to help suppress seizures and improve these comorbidities. This&amp;nbsp;technology&amp;nbsp;allows care to extend beyond the clinic and into a patient's home.&amp;nbsp;</p>



<p><strong>What kinds of devices are being developed through BIONIC?</strong>&amp;nbsp;<br>We're&amp;nbsp;developing&amp;nbsp;a&amp;nbsp;next-generation neuromodulation&amp;nbsp;platform with&amp;nbsp;devices that are fully implantable&amp;nbsp;and integrated with wearables and computing. These devices include electrodes placed in the brain and have sensing capabilities that allow continuous recording of brain activity. The data can be securely transmitted through a handheld device to the cloud. The system enables analysis that can guide therapy&amp;nbsp;and&amp;nbsp;drive&amp;nbsp;better&amp;nbsp;understanding of&amp;nbsp;seizures and related conditions.&amp;nbsp;</p>



<p><strong>What can clinicians and researchers learn from this brain data?</strong>&amp;nbsp;<br>By continuously recording brain activity, we can track seizures, sleep patterns,&amp;nbsp;memory&amp;nbsp;and mood. This data allows us to adjust electrical therapies in a more personalized way.&amp;nbsp;Ultimately, our&amp;nbsp;goal is to forecast seizures before they happen and deliver adaptive therapies that&amp;nbsp;prevent&amp;nbsp;seizures&amp;nbsp;before they occur&amp;nbsp;and address the broader impact of epilepsy on daily life.&amp;nbsp;</p>



<p><strong>How do these new devices compare to earlier generations?</strong>&amp;nbsp;<br>Earlier devices were groundbreaking for their time, but they had fewer capabilities. The devices&amp;nbsp;we're&amp;nbsp;preparing for clinical trials are significantly smaller, more powerful,&amp;nbsp;rechargeable&amp;nbsp;and offer expanded&amp;nbsp;stimulation,&amp;nbsp;sensing&amp;nbsp;and streaming capabilities. This&amp;nbsp;represents&amp;nbsp;a major step forward in both technology and patient experience.&amp;nbsp;</p>



<p><strong>What is the long-term vision of the BIONIC Initiative?</strong>&amp;nbsp;<br>Our vision is to build more effective therapies, prevent seizures before they&amp;nbsp;occur&amp;nbsp;and directly target comorbidities. With current&amp;nbsp;newly developed&amp;nbsp;technologies, these goals are now achievable, and BIONIC is focused on translating them into real-world patient benefits.&amp;nbsp;</p>



<p><strong>Why is collaboration beyond Mayo Clinic essential?</strong>&amp;nbsp;<br>These challenges&amp;nbsp;can't&amp;nbsp;be solved by one person or one institution alone. Collaboration with other academic centers, industry&amp;nbsp;partners&amp;nbsp;and most importantly,&amp;nbsp;patients is essential. A technology that&amp;nbsp;doesn't&amp;nbsp;have a clear path to commercialization, even if&amp;nbsp;it's&amp;nbsp;innovative, will&amp;nbsp;likely&amp;nbsp;only&amp;nbsp;help a&amp;nbsp;relatively&amp;nbsp;small&amp;nbsp;number of people.&amp;nbsp;</p>



<p><strong>How do patients factor into the development of these therapies?</strong>&amp;nbsp;<br>Partnering with patients is critical. We need to understand what matters most to them&amp;nbsp;and&amp;nbsp;what they need to improve their quality of life. Their input helps guide technology development&amp;nbsp;so that it truly addresses real-world needs.&amp;nbsp;</p>



<p><strong>What is the&amp;nbsp;ultimate goal&amp;nbsp;of BIONIC?</strong>&amp;nbsp;<br>The goal of BIONIC is to bring&amp;nbsp;all of&amp;nbsp;these elements together into a unified effort to create the future of epilepsy therapy — one that is more personalized,&amp;nbsp;proactive&amp;nbsp;and focused on the whole patient.&amp;nbsp;It is important to realize that&amp;nbsp;the neuromodulation&amp;nbsp;technologies developed for epilepsy will have&amp;nbsp;a&amp;nbsp;wide impact on many other diseases of the brain and mind.&amp;nbsp;<br>&amp;nbsp;<br><strong>###&amp;nbsp;</strong>&amp;nbsp;</p>



<p><strong>About Mayo&amp;nbsp;Clinic&amp;nbsp;</strong>&amp;nbsp;<br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&amp;nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion,&amp;nbsp;expertise&amp;nbsp;and answers to everyone who needs healing. Visit the&amp;nbsp;<a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a>&amp;nbsp;for&amp;nbsp;additional&amp;nbsp;Mayo Clinic news.&amp;nbsp;&amp;nbsp;</p>



<p><strong>Media contact:</strong>&amp;nbsp;</p>



<ul class="wp-block-list">
<li>Tia Ford, Mayo Clinic Communications,&amp;nbsp;<a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a>&amp;nbsp;&amp;nbsp;<br>&amp;nbsp;<br>&amp;nbsp;</li>
</ul>



<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/advancing-epilepsy-care-mayo-clinic-neurologist-dr-gregory-worrell/">Advancing&nbsp;epilepsy&nbsp;care:&nbsp;Mayo Clinic neurologist&nbsp;Dr. Gregory Worrell&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/GregoryWorrell1x1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/GregoryWorrell16x9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Gregory Worrell]]></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic uses gene editing to reverse inherited kidney disease in preclinical study</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-uses-gene-editing-to-reverse-inherited-kidney-disease-in-preclinical-study/</link>
		
		<dc:creator><![CDATA[Kelley Luckstein]]></dc:creator>
		<pubDate>Thu, 29 Jan 2026 13:45:23 +0000</pubDate>
				<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Minnesota]]></category>
		<category><![CDATA[News Releases]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Xiaogang Li]]></category>
		<category><![CDATA[Minnesota News Releases]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409935</guid>

					<description><![CDATA[<p>ROCHESTER, Minn. — Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible for autosomal dominant polycystic kidney disease (ADPKD), the most common inherited kidney disorder. A single treatment of the gene therapy slowed kidney cyst growth, improved heart and liver health, and extended survival in preclinical models of [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-uses-gene-editing-to-reverse-inherited-kidney-disease-in-preclinical-study/">Mayo Clinic uses gene editing to reverse inherited kidney disease in preclinical study</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Researchers-and-laboratory-technicians-work-in-a-busy-laboratory_WF4324336_0165-1024x576.jpg" alt="Researchers and laboratory technicians work in a laboratory" class="wp-image-409985" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Researchers-and-laboratory-technicians-work-in-a-busy-laboratory_WF4324336_0165-1024x576.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Researchers-and-laboratory-technicians-work-in-a-busy-laboratory_WF4324336_0165-300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Researchers-and-laboratory-technicians-work-in-a-busy-laboratory_WF4324336_0165-768x432.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Researchers-and-laboratory-technicians-work-in-a-busy-laboratory_WF4324336_0165-1536x864.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Researchers-and-laboratory-technicians-work-in-a-busy-laboratory_WF4324336_0165.jpg 2000w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<p>ROCHESTER, Minn. — <a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible for autosomal dominant <a href="https://newsnetwork.mayoclinic.org/discussion/science-saturday-confronting-polycystic-kidney-disease-a-silent-killer/?cjdata=MXxOfDB8WXww&amp;amp;cjevent=0a8219cbe9d911f082600abd0a82b821&amp;amp;cm_mmc=CJ-_-100357191-_-5250933-_-Evergreen+Link+for+Mayo+Clinic+Diet&amp;amp;utm_source=cj&amp;amp;utm_content=100357191&amp;amp;utm_capaign=3-months" target="_blank" rel="noreferrer noopener">polycystic kidney disease</a> (ADPKD), the most common inherited kidney disorder.</p>



<p>A single treatment of the gene therapy slowed kidney cyst growth, improved heart and liver health, and extended survival in preclinical models of ADPKD. The findings were <a href="https://www.nature.com/articles/s41467-025-65997-1" target="_blank" rel="noreferrer noopener">published</a> in Nature Communications.</p>


<div class="wp-block-image">
<figure class="alignright size-medium"><img decoding="async" width="262" height="300" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Xiaogang-Li-262x300.jpg" alt="Portrait of Dr. Xiaogang Li" class="wp-image-409980" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Xiaogang-Li-262x300.jpg 262w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Xiaogang-Li.jpg 682w" sizes="(max-width: 262px) 100vw, 262px" /><figcaption class="wp-element-caption">Xiaogang Li, Ph.D.</figcaption></figure>
</div>


<p>"This is the first time we've been able to show that base editing can effectively and safely correct a disease-causing mutation in the kidney in a complex biological system," says <a href="https://www.mayo.edu/research/faculty/li-xiaogang-ph-d/bio-20453268" target="_blank" rel="noreferrer noopener">Xiaogang Li, Ph.D.</a>, nephrology researcher and senior author of the study. "Instead of managing symptoms, this strategy goes after the underlying cause of the disease."</p>



<p><a href="https://www.mayoclinic.org/diseases-conditions/polycystic-kidney-disease/symptoms-causes/syc-20352820?cjdata=MXxOfDB8WXww&amp;amp;cjevent=71874690e9d911f082ee0b1f0a82b836&amp;amp;cm_mmc=CJ-_-100357191-_-5250933-_-Evergreen+Link+for+Mayo+Clinic+Diet&amp;amp;utm_source=cj&amp;amp;utm_content=100357191&amp;amp;utm_capaign=3-months" target="_blank" rel="noreferrer noopener">ADPKD</a> affects an estimated 12 million people worldwide. The disease is caused primarily by mutations in the PKD1 or PKD2 genes and leads to the progressive growth of fluid-filled cysts in the kidneys, often resulting in kidney failure. Many patients also develop complications outside the kidneys, including heart enlargement and liver disease.</p>



<p>Current treatments can slow disease progression but do not address its genetic root. The new approach, developed by Mayo Clinic investigators, uses a form of <a href="https://newsnetwork.mayoclinic.org/discussion/science-saturday-the-gene-editing-tool-crispr-explained/?cjdata=MXxOfDB8WXww&amp;amp;cjevent=b0050e8de9d811f082600abd0a82b821&amp;amp;cm_mmc=CJ-_-100357191-_-5250933-_-Evergreen+Link+for+Mayo+Clinic+Diet&amp;amp;utm_source=cj&amp;amp;utm_content=100357191&amp;amp;utm_capaign=3-months" target="_blank" rel="noreferrer noopener">CRISPR-based gene editing</a> known as base editing to precisely correct a single-letter DNA mutation in the PKD1 gene.</p>



<p>In the study, researchers engineered two versions of a base editor: one designed to work broadly across multiple organs and another tailored specifically to kidney cells. Delivered using adeno-associated virus (AAV) vectors, a single dose of the therapy corrected the PKD1 mutation in a significant proportion of cells in kidney tissue and, depending on the editor used, in the heart and liver as well.</p>


<div class="wp-block-image">
<figure class="alignleft size-medium"><img loading="lazy" decoding="async" width="300" height="250" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/4250422-001-0-72ppi-300x250.jpg" alt="Illustration of a healthy kidney and a polycystic kidney" class="wp-image-409981" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/4250422-001-0-72ppi-300x250.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/4250422-001-0-72ppi.jpg 632w" sizes="auto, (max-width: 300px) 100vw, 300px" /></figure>
</div>


<p>Preclinical models treated early in life had significantly reduced kidney cyst growth, better kidney function, less heart enlargement, improved liver health and longer survival. Importantly, the researchers found no evidence of harmful off-target genetic changes or significant immune reactions.</p>



<p>"Our results suggest this could one day be a treatment that meaningfully changes the course of disease," Dr. Li says. "That is fundamentally different from lifelong therapies that only slow progression."</p>



<p>The kidney has historically been difficult to target with gene-editing therapies. This study provides the first in vivo evidence that base editing can work efficiently in kidney tissue, opening the door to similar approaches for other inherited kidney diseases.</p>



<p>The research team also demonstrated that kidney-specific gene editing can limit genetic changes to the intended organ, a strategy that may enhance safety as therapies move closer to human testing.</p>



<p>"Being able to precisely control where editing happens is critical," Dr. Li says. "It allows us to maximize benefit while minimizing risk."<strong></strong></p>



<p>The work advances Mayo Clinic's Genesis initiative, which aims to prevent organ failure and restore function through regenerative medicine, precision genomics and advanced therapies.&amp;nbsp;</p>



<p>Ongoing studies are focused on refining base-editing tools to address a broader range of PKD mutations, evaluating whether treatment can be effective after cysts have already formed, and developing alternative delivery methods — including nonviral options such as nanoparticles — to support future clinical use.</p>



<p>"If these approaches translate successfully to humans, they could reduce or even eliminate the need for chronic medication, delay kidney failure and significantly improve quality of life for patients with ADPKD," Dr. Li says.</p>



<p>For a complete list of authors, disclosures and funding, review the&amp;nbsp;<a href="https://www.nature.com/articles/s41467-025-65997-1" target="_blank" rel="noreferrer noopener">study</a>.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;</p>



<p>###&amp;nbsp;&amp;nbsp;</p>



<p><strong>About Mayo Clinic</strong> <br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Kelley Luckstein, Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-uses-gene-editing-to-reverse-inherited-kidney-disease-in-preclinical-study/">Mayo Clinic uses gene editing to reverse inherited kidney disease in preclinical study</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Researchers-and-laboratory-technicians-work-in-a-busy-laboratory_WF4324336_0165_1x1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Researchers-and-laboratory-technicians-work-in-a-busy-laboratory_WF4324336_0165.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Xiaogang Li]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Minnesota News Releases]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[News Releases]]></mayoclinic:mctag>	</item>
		<item>
		<title>Rewriting the future of rheumatoid arthritis: How early detection is transforming prevention&nbsp;</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/rewriting-the-future-of-rheumatoid-arthritis-how-early-detection-is-transforming-prevention/</link>
		
		<dc:creator><![CDATA[jftmayo]]></dc:creator>
		<pubDate>Wed, 28 Jan 2026 17:05:33 +0000</pubDate>
				<category><![CDATA[AI and Digital Health]]></category>
		<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Medical Innovation]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Tomorrow's Cure]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409916</guid>

					<description><![CDATA[<p>This episode of&nbsp;the&nbsp;"Tomorrow's&nbsp;Cure"&nbsp;podcast&nbsp;discusses developments in rheumatoid arthritis research and the emerging technologies shaping&nbsp;what's&nbsp;possible in care. Featuring&nbsp;Dr. John Davis, III, Mayo Clinic rheumatologist and Dr. Kevin Deane, University of Colorado rheumatologist, the episode highlights how early‑stage research and emerging technologies are reshaping&nbsp;what's&nbsp;possible in rheumatoid arthritis care.&nbsp; Rheumatoid arthritis&nbsp;is an autoimmune condition that affects far more than [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/rewriting-the-future-of-rheumatoid-arthritis-how-early-detection-is-transforming-prevention/">Rewriting the future of rheumatoid arthritis: How early detection is transforming prevention&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Rheumatology_YT-Thumbnail_1280x720-1024x576.png" alt="Graphic for Tomorrow's Cure episode 2 Predictive Medicine: Rethinking Rheumatoid Arthritis" class="wp-image-409920" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Rheumatology_YT-Thumbnail_1280x720-1024x576.png 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Rheumatology_YT-Thumbnail_1280x720-300x169.png 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Rheumatology_YT-Thumbnail_1280x720-768x432.png 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Rheumatology_YT-Thumbnail_1280x720.png 1280w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></figure>



<p>This episode of&nbsp;the&nbsp;"<a href="https://www.youtube.com/watch?v=mPeC3QIslqI" target="_blank" rel="noreferrer noopener">Tomorrow's&nbsp;Cure</a>"&nbsp;podcast&nbsp;discusses developments in <a href="https://www.mayoclinic.org/diseases-conditions/rheumatoid-arthritis/symptoms-causes/syc-20353648" target="_blank" rel="noreferrer noopener">rheumatoid arthritis</a> research and the emerging technologies shaping&nbsp;what's&nbsp;possible in care. Featuring&nbsp;<a href="https://www.mayo.edu/research/faculty/davis-john-m-iii-m-d/bio-00027697" target="_blank" rel="noreferrer noopener">Dr. John Davis, III</a>, Mayo Clinic rheumatologist and Dr. Kevin Deane, University of Colorado rheumatologist, the episode highlights how early‑stage research and emerging technologies are reshaping&nbsp;what's&nbsp;possible in rheumatoid arthritis care.&nbsp;</p>



<p>Rheumatoid arthritis&nbsp;is an autoimmune condition that affects far more than joints. Crucially, researchers now know that autoantibodies,&nbsp;such as anti-cyclic citrullinated peptide (anti‑CCP)&nbsp;and <a href="https://www.mayoclinic.org/tests-procedures/rheumatoid-factor/about/pac-20384800" target="_blank" rel="noreferrer noopener">rheumatoid factor</a>,&nbsp;often develop years before diagnosis, signaling early immune system disruption.&nbsp;</p>



<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<div class="fluidEmbed"><iframe loading="lazy" id="videoidmPeC3QIslqI"  title="Predictive Medicine: Rethinking Rheumatoid Arthritis | Tomorrow&amp;#039;s Cure Season 4 Episode 2" width="500" height="281" src="https://www.youtube.com/embed/mPeC3QIslqI?feature=oembed&amp;enablejsapi=1" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe></div>
</div></figure>



<p>Traditional blood tests&amp;nbsp;predict&amp;nbsp;future&amp;nbsp;rheumatoid arthritis&amp;nbsp;only&amp;nbsp;about 30% of the time&amp;nbsp;—&amp;nbsp;too uncertain for preventive treatment. To close this gap, researchers&amp;nbsp;turn&amp;nbsp;to AI and&amp;nbsp;multisource&amp;nbsp;data&amp;nbsp;such as genetic information, lifestyle and environmental exposures, microbiome patterns, imaging and clinical records,&amp;nbsp;and wearable health metrics.&amp;nbsp;AI can piece together complex risk profiles that traditional methods&amp;nbsp;can't, helping&amp;nbsp;identify&amp;nbsp;individuals most likely to develop the disease and when.&amp;nbsp;</p>



<p>New evidence suggests&amp;nbsp;rheumatoid arthritis&amp;nbsp;may start at mucosal surfaces&amp;nbsp;such&amp;nbsp;as the lungs,&amp;nbsp;gut&amp;nbsp;or gums&amp;nbsp;before affecting joints. Environmental factors&amp;nbsp;such as&amp;nbsp;smoke,&amp;nbsp;pollution&amp;nbsp;and airborne particles may play a role in triggering early immune activation.&amp;nbsp;</p>



<p>At the same time, the gut microbiome is&amp;nbsp;emerging&amp;nbsp;as a powerful predictor of both&amp;nbsp;rheumatoid arthritis&amp;nbsp;risk and treatment response. Certain bacteria influence inflammation and can even&amp;nbsp;metabolize medications such as methotrexate, affecting how well patients respond.&amp;nbsp;</p>



<p>Over the next decade, experts&amp;nbsp;anticipate&amp;nbsp;transformative shifts in rheumatology,&amp;nbsp;including more precise biomarkers and antibody panels;&amp;nbsp;AI-guided prediction tools that can lead to personalized, data-driven treatment plans;&amp;nbsp;expanded virtual care options to increase access;&amp;nbsp;and a deeper understanding of environmental and immune triggers.&amp;nbsp;&amp;nbsp;</p>



<p>"I think this is where we need to go&amp;nbsp;… trying to put together a lot of data that we can digitize about an individual,&amp;nbsp;such as&amp;nbsp;health, risk factors, behaviors, even wearable data,&amp;nbsp;and analyze it&amp;nbsp;using AI to identify people who could be at risk long before symptoms appear,"&amp;nbsp;Dr.&amp;nbsp;Davis&amp;nbsp;says. The long‑term goal is clear:&amp;nbsp;identify&amp;nbsp;rheumatoid arthritis&amp;nbsp;before joint damage occurs&amp;nbsp;and&amp;nbsp;ultimately prevent&amp;nbsp;the disease altogether.&amp;nbsp;</p>



<p>Listen to the latest episode of&nbsp;"<a href="https://careinfo.mayoclinic.org/tomorrows-cure-podcast?mc_id=global&amp;amp;utm_source=newsnetwork&amp;amp;utm_medium=l&amp;amp;utm_content=tcseasonthreeepisodeone&amp;amp;utm_campaign=mayoclinic&amp;amp;geo=global&amp;amp;placementsite=enterprise&amp;amp;invsrc=other&amp;amp;cauid=193335" target="_blank" rel="noreferrer noopener">Tomorrow's Cure</a>"&nbsp;wherever you get your podcasts. You can explore the full library of episodes and guests on the&nbsp;show's&nbsp;<a href="https://www.youtube.com/playlist?list=PLSWR1ylG_6JZd7nHPPgpIaoq_iRHgXRoF" target="_blank" rel="noreferrer noopener">page</a>.&nbsp;</p>



<p></p>



<p></p>



<p><br></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/rewriting-the-future-of-rheumatoid-arthritis-how-early-detection-is-transforming-prevention/">Rewriting the future of rheumatoid arthritis: How early detection is transforming prevention&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Rheumatology_Episode-Art_3000x3000.png</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Rheumatology_YT-Thumbnail_1280x720.png</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Rheumatoid Arthritis]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Tomorrow's Cure]]></mayoclinic:mctag>	</item>
		<item>
		<title>Global study identifies gap between expectations, experience in perimenopause</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/global-study-identifies-gap-between-expectations-experience-in-perimenopause/</link>
		
		<dc:creator><![CDATA[rebeccabromelkamp]]></dc:creator>
		<pubDate>Wed, 28 Jan 2026 14:01:00 +0000</pubDate>
				<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Mary Hedges]]></category>
		<category><![CDATA[Florida News Releases]]></category>
		<category><![CDATA[News Releases]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409941</guid>

					<description><![CDATA[<p>JACKSONVILLE, Fla. — A new international study — believed to be the largest of its kind — examined what people know about perimenopause and what symptoms they experience. The results reveal a clear gap between what perimenopause symptoms people expect and what they experience. Mayo Clinic researchers published a collaborative research study with Flo, a [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/global-study-identifies-gap-between-expectations-experience-in-perimenopause/">Global study identifies gap between expectations, experience in perimenopause</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Women-look-at-cellphone-in-cafe_GettyImages-1456857560-1024x683.jpg" alt="Women look at cellphone in cafe" class="wp-image-409947" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Women-look-at-cellphone-in-cafe_GettyImages-1456857560-1024x683.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Women-look-at-cellphone-in-cafe_GettyImages-1456857560-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Women-look-at-cellphone-in-cafe_GettyImages-1456857560-768x512.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Women-look-at-cellphone-in-cafe_GettyImages-1456857560-1536x1024.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Women-look-at-cellphone-in-cafe_GettyImages-1456857560.jpg 1687w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></figure>



<p>JACKSONVILLE, Fla. — A new international study — believed to be the largest of its kind — examined what people know about perimenopause and what symptoms they experience. The results reveal a clear gap between what perimenopause symptoms people expect and what they experience.</p>



<p><a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> researchers published a collaborative research <a href="https://journals.lww.com/menopausejournal/fulltext/9900/global_perspectives_on_perimenopause__a_digital.602.aspx" target="_blank" rel="noreferrer noopener">study</a> with Flo, a women's health application, to assess the <a href="https://www.mayoclinic.org/diseases-conditions/perimenopause/symptoms-causes/syc-20354666" target="_blank" rel="noreferrer noopener">perimenopause</a> symptoms of 17,494 people from 158 countries. The study results are published in <a href="https://menopause.org/professional-resources/menopause-journal-nm" target="_blank" rel="noreferrer noopener">Menopause</a>, the official journal of The Menopause Society.</p>



<p>Perimenopause marks the time leading up to the final menstrual period and includes the year after it ends. This transition can begin as early as the 30s and last for several years. Although it affects health and daily life, researchers have studied it far less than <a href="https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397" target="_blank" rel="noreferrer noopener">menopause</a>.</p>



<p>"This study shines a light on how little we still understand about perimenopause and how much it affects people's daily lives," says first author <a href="https://www.mayoclinic.org/biographies/hedges-mary-s-m-d/bio-20055284" target="_blank" rel="noreferrer noopener">Mary Hedges, M.D.</a>, a community internal medicine physician at <a href="https://www.mayoclinic.org/patient-visitor-guide/florida" target="_blank" rel="noreferrer noopener">Mayo Clinic in Florida</a>. "At Mayo Clinic, we're working to expand that understanding so we can improve awareness and guide care that truly meets the needs of each patient."</p>



<p>Among more than 12,000 participants over age 35, the most common reported symptoms were fatigue (83%), exhaustion (83%), irritability (80%), low mood (77%), sleep problems (76%), digestive issues (76%) and anxiety (75%).</p>



<p>When asked what they associate with perimenopause, participants most often named hot flashes (71%), sleep problems (68%) and weight gain (65%). However, for those who said they were in perimenopause, 95% reported exhaustion and 93% reported <a href="https://www.mayoclinic.org/symptoms/fatigue/basics/causes/sym-20050894" target="_blank" rel="noreferrer noopener">fatigue</a> — far higher than the rate of hot flashes. Exhaustion is a general decrease in performance, impaired memory, decreased concentration, and forgetfulness, whereas fatigue is physical exhaustion.</p>



<p>These findings show that fatigue, mood changes and sleep-related issues are central to many people's perimenopause experiences, the study authors say. Hormone changes may affect the body's natural rhythms and restorative sleep, while mood changes can be influenced by hormones, inflammation and diet.</p>



<p>The research highlights that perimenopause symptoms can significantly affect daily life, relationships and work. Responsibilities such as caregiving and coexisting health conditions may add to the strain, increasing fatigue and emotional stress.</p>



<p>Mayo Clinic researchers say the study underscores the importance of rethinking how clinicians approach midlife health. They emphasize that understanding what people are truly experiencing — not just what is traditionally expected — is essential to improving care and communication during this life stage.</p>



<p>Mayo Clinic continues to study how biological, lifestyle and social factors influence perimenopause symptoms and how greater awareness can help improve patient care. This work supports Mayo Clinic's vision to transform the practice of medicine through research that addresses real-world needs and leads to more informed, compassionate care.</p>



<p>###</p>



<p><strong>About Mayo Clinic</strong><br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Julie Ferris-Tillman, Ph.D., Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/global-study-identifies-gap-between-expectations-experience-in-perimenopause/">Global study identifies gap between expectations, experience in perimenopause</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Women-look-at-cellphone-in-cafe_GettyImages-1456857560_1x1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Women-look-at-cellphone-in-cafe_GettyImages-1456857560_16x9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Mary Hedges]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Florida News Releases]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[News Releases]]></mayoclinic:mctag>	</item>
		<item>
		<title>New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/new-study-links-combination-of-hormone-therapy-and-tirzepatide-to-greater-weight-loss-after-menopause/</link>
		
		<dc:creator><![CDATA[Jessica Saenz]]></dc:creator>
		<pubDate>Thu, 22 Jan 2026 23:31:00 +0000</pubDate>
				<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[News Releases]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Maria Daniela Hurtado Andrade]]></category>
		<category><![CDATA[Dr. Regina Castaneda]]></category>
		<category><![CDATA[Florida News Releases]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409761</guid>

					<description><![CDATA[<p>JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the treatment of overweight and obesity. The findings, published in The Lancet Obstetrics, Gynaecology, &amp;#38; Women's Health, could expand treatment possibilities for millions [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/new-study-links-combination-of-hormone-therapy-and-tirzepatide-to-greater-weight-loss-after-menopause/">New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="682" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Portrait-if-a-yarn-store-owner-standing-in-front-of-a-rack-of-yarn_GettyImages-2211563357-1024x682.jpg" alt="Portrait if a middle-aged woman yarn store owner standing in front of a rack of yarn" class="wp-image-409775" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Portrait-if-a-yarn-store-owner-standing-in-front-of-a-rack-of-yarn_GettyImages-2211563357-1024x682.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Portrait-if-a-yarn-store-owner-standing-in-front-of-a-rack-of-yarn_GettyImages-2211563357-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Portrait-if-a-yarn-store-owner-standing-in-front-of-a-rack-of-yarn_GettyImages-2211563357-768x511.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Portrait-if-a-yarn-store-owner-standing-in-front-of-a-rack-of-yarn_GettyImages-2211563357-1536x1022.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Portrait-if-a-yarn-store-owner-standing-in-front-of-a-rack-of-yarn_GettyImages-2211563357.jpg 1690w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></figure>



<p>JACKSONVILLE, Fla. — A new study led by <a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking <a href="https://www.mayoclinic.org/drugs-supplements/tirzepatide-subcutaneous-route/description/drg-20534045" target="_blank" rel="noreferrer noopener">tirzepatide</a>, a Food and Drug Administration-approved drug for the treatment of overweight and obesity. The findings, published in <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flanogw%2Farticle%2FPIIS3050-5038(25)00145-1%2Ffulltext&amp;amp;data=05%7C02%7CSaenz.Jessica%40mayo.edu%7Ce48ccd7048a14ce4fa7908de592723a7%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C639046222303357075%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;amp;sdata=nXamtX8R0iOLgYrT2hxqtpCJUZHYHlrXz15w%2BxMpL7o%3D&amp;amp;reserved=0" target="_blank" rel="noreferrer noopener">The Lancet Obstetrics, Gynaecology, &amp;amp; Women's Health</a>, could expand treatment possibilities for millions of women struggling with obesity and obesity-related diseases after menopause.</p>


<div class="wp-block-image">
<figure class="alignright size-medium"><img loading="lazy" decoding="async" width="300" height="300" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Castaneda-300x300.jpg" alt="portrait of Dr. Regina Castaneda" class="wp-image-409769" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Castaneda-300x300.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Castaneda-150x150.jpg 150w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Castaneda.jpg 404w" sizes="auto, (max-width: 300px) 100vw, 300px" /><figcaption class="wp-element-caption">Regina Castaneda, M.D.</figcaption></figure>
</div>


<p><a href="https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397" target="_blank" rel="noreferrer noopener">Menopause</a> can accelerate age-related weight gain and increase the likelihood of developing overweight and obesity, which are major risk factors for cardiovascular disease, type 2 diabetes and other conditions. The decline in estrogen levels characteristic of menopause is also linked to changes independent of weight that can potentially raise <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-menopause-and-the-heart-connection/" target="_blank" rel="noreferrer noopener">cardiovascular risk</a>. "This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women," says Regina Castaneda, M.D., postdoctoral research fellow at Mayo Clinic and first author of the study.</p>



<p><a href="https://www.mayoclinic.org/diseases-conditions/menopause/in-depth/hormone-therapy/art-20046372" target="_blank" rel="noreferrer noopener">Hormone therapy</a> is the most effective first-line treatment for menopausal symptoms, including hot flashes and night sweats, which affect up to 75% of postmenopausal women. While evidence on how this therapy may interact with weight-loss medications is limited, some research has shown that postmenopausal women using hormone therapy experience greater weight loss when treated with the GLP-1-based obesity medication <a href="https://www.mayoclinic.org/drugs-supplements/semaglutide-subcutaneous-route/description/drg-20406730" target="_blank" rel="noreferrer noopener">semaglutide</a>.</p>



<p>No previous studies have examined whether hormone therapy might influence outcomes with tirzepatide. Dr. Castaneda and a team of researchers set out to investigate this relationship by reviewing data from 120 participants with overweight or obesity who received tirzepatide for weight management for 12 or more months. Patients receiving tirzepatide along with hormone therapy were compared to participants with similar characteristics who were not using hormone therapy.</p>


<div class="wp-block-image">
<figure class="alignleft size-medium"><img loading="lazy" decoding="async" width="300" height="300" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Hurtado-300x300.jpg" alt="Portrait of Dr. Maria Daniela Hurtado Andrade" class="wp-image-409768" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Hurtado-300x300.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Hurtado-150x150.jpg 150w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Hurtado.jpg 486w" sizes="auto, (max-width: 300px) 100vw, 300px" /><figcaption class="wp-element-caption">Maria Daniela Hurtado Andrade, M.D., Ph.D.</figcaption></figure>
</div>


<p>"In this observational study, women who used menopausal hormone therapy lost about 35% more weight than women taking tirzepatide alone. Because this was not a randomized trial, we cannot say hormone therapy caused additional weight loss," says <a href="https://www.mayo.edu/research/faculty/hurtado-andrade-maria-daniela-m-d-ph-d/bio-20490372" target="_blank" rel="noreferrer noopener">Maria Daniela Hurtado Andrade, M.D., Ph.D.</a>, endocrinologist at Mayo Clinic and senior author of the study.</p>



<p>"It is possible that women using hormone therapy were already engaged in healthier behaviors, or that menopause symptom relief improved sleep and quality of life, making it easier to stay engaged with dietary and physical activity changes."</p>



<p>Dr. Castaneda says, while more studies that control for these factors are needed, the findings are clinically meaningful. "The magnitude of this difference warrants future studies that could help clarify how GLP-1-based obesity medications and menopausal hormone therapy may interact. Interestingly, preclinical data suggest a potential synergy, with estrogen appearing to enhance the appetite-suppressing effects of GLP-1," says Dr. Castaneda.</p>



<p>"Next, we plan to test these observations in a randomized clinical trial and determine if benefits extend beyond weight loss — specifically, whether hormone therapy also enhances the effects of these medications on cardiometabolic measures," adds Dr. Hurtado Andrade. "If confirmed, this work could speed the development and adoption of new, evidence-based strategies to reduce this risk for millions of postmenopausal women navigating this life stage."</p>



<p>This research was funded by the Mayo Clinic Center for Women's Health Research. Review the <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flanogw%2Farticle%2FPIIS3050-5038(25)00145-1%2Ffulltext&amp;amp;data=05%7C02%7CSaenz.Jessica%40mayo.edu%7Ce48ccd7048a14ce4fa7908de592723a7%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C639046222303357075%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;amp;sdata=nXamtX8R0iOLgYrT2hxqtpCJUZHYHlrXz15w%2BxMpL7o%3D&amp;amp;reserved=0" target="_blank" rel="noreferrer noopener">study</a> for a complete list of authors, disclosures and funding.</p>



<p>###</p>



<p><strong>About Mayo Clinic</strong> <br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Tia Ford, Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/new-study-links-combination-of-hormone-therapy-and-tirzepatide-to-greater-weight-loss-after-menopause/">New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Portrait-if-a-yarn-store-owner-standing-in-front-of-a-rack-of-yarn_GettyImages-2211563357_1x1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Portrait-if-a-yarn-store-owner-standing-in-front-of-a-rack-of-yarn_GettyImages-2211563357_16x9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Maria Daniela Hurtado Andrade]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Regina Castaneda]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Florida News Releases]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[News Releases]]></mayoclinic:mctag>	</item>
		<item>
		<title>Tomorrow&amp;#8217;s Cure: 3D bioprinting living human skin to improve wound care,&nbsp;testing&nbsp;</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/tomorrows-cure-3d-bioprinting-living-human-skin-to-improve-wound-care-testing/</link>
		
		<dc:creator><![CDATA[jftmayo]]></dc:creator>
		<pubDate>Wed, 21 Jan 2026 13:40:06 +0000</pubDate>
				<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Podcast]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Saranya Wyles]]></category>
		<category><![CDATA[Tomorrow's Cure]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409620</guid>

					<description><![CDATA[<p>On this week's launch of the fourth season of "Tomorrow's Cure," the first episode features two pioneers at the intersection of biology and technology. Together, they explore a fast-moving frontier in regenerative medicine: 3D bioprinting living, humanized skin models&amp;#160;built from real human cells and biologic building blocks. The podcast episode features&nbsp;Saranya Wyles, M.D., Ph.D.,&nbsp;a dermatologist [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/tomorrows-cure-3d-bioprinting-living-human-skin-to-improve-wound-care-testing/">Tomorrow&amp;#8217;s Cure: 3D bioprinting living human skin to improve wound care,&nbsp;testing&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="wp-block-image">
<figure class="aligncenter size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Skinspan-Bioprinting_YT-Thumbnail_1280x720-1024x576.jpg" alt="Graphic for Tomorrow's Cure, episode 1 3D skin 16x9" class="wp-image-409653" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Skinspan-Bioprinting_YT-Thumbnail_1280x720-1024x576.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Skinspan-Bioprinting_YT-Thumbnail_1280x720-300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Skinspan-Bioprinting_YT-Thumbnail_1280x720-768x432.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Skinspan-Bioprinting_YT-Thumbnail_1280x720.jpg 1280w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></figure>
</div>


<p>On this week's launch of the fourth season of "<a href="https://careinfo.mayoclinic.org/tomorrows-cure-podcast?mc_id=global&amp;amp;utm_source=newsnetwork&amp;amp;utm_medium=l&amp;amp;utm_content=tcseasontwoepisodeeight&amp;amp;utm_campaign=mayoclinic&amp;amp;geo=global&amp;amp;placementsite=enterprise&amp;amp;invsrc=other&amp;amp;cauid=190207">Tomorrow's Cure</a>," the first episode features two pioneers at the intersection of biology and technology. Together, they explore a fast-moving frontier in regenerative medicine: 3D bioprinting living, humanized skin model<strong>s</strong>&amp;nbsp;built from real human cells and biologic building blocks.</p>



<p>The podcast episode features&nbsp;<a href="https://www.mayoclinic.org/biographies/wyles-saranya-p-m-d-ph-d/bio-20518649">Saranya Wyles, M.D., Ph.D</a>.,&nbsp;a dermatologist at&nbsp;<a href="https://www.mayoclinic.org/about-mayo-clinic">Mayo Clinic</a>&nbsp;in Rochester, and&nbsp;<a href="https://www.cmu.edu/bme/People/Faculty/profile/afeinberg.html">Adam Feinberg, Ph.D.</a>, principal investigator of the Regenerative Biomaterials and Therapeutics Group at Carnegie Mellon University.</p>



<p>Dr. Wyles describes skin as a set of "cake layers," including the epidermis, dermis and hypodermis. She proposes that people think about skin span. "It's an idea derived from health span and life span. Our concept is that we can have optimally functioning skin at the level of structure but also at the level of its function, serving as a barrier preventing infection for longer," Dr. Wyles says. "The skin is a mirror to your systemic health."&amp;nbsp;</p>



<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<div class="fluidEmbed"><iframe loading="lazy" id="videoidPsni7MsovIA"  title="3D Bioprinted Skin: Breakthroughs in Regenerative Medicine | Tomorrow&amp;#039;s Cure Season 4 Episode 1" width="500" height="281" src="https://www.youtube.com/embed/Psni7MsovIA?feature=oembed&amp;enablejsapi=1" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe></div>
</div></figure>



<p>A major goal is to model how skin changes over time because collagen and structure in younger skin can look very different from older skin. That's key for understanding healing, chronic wounds and how therapies may behave across ages and skin tones.</p>



<p>"We're using these advanced technologies to try to augment the body's ability to rebuild tissue structure," Dr. Feinberg says. He explains that collagen is the body's primary structural protein, so his lab focuses on bioprinting collagen in ways that mimic native tissue at microscopic scales. Using biologic materials rather than synthetic ones helps printed tissues behave more like the real thing and may improve how future implants integrate with the body.&amp;nbsp;</p>



<p>Dr. Wyles highlights the team's work toward diagnostic and preclinical testing uses, with an emphasis on building an alternative to animal models. Printed skin can be observed as a living system, measured through its structure and secreted signals, then challenged with topical therapies to see how it responds.</p>



<p>Dr. Feinberg adds that moving away from animal testing is a growing priority, and engineered human tissue models may improve prediction because animal physiology differs from humans. The shared challenge is validation: proving that the models are reproducible and reliably predictive.</p>



<p>The episode also digs into senescent "<a href="https://newsnetwork.mayoclinic.org/discussion/a-new-tool-to-find-hidden-zombie-cells/">zombie cells</a>," which stop dividing but do not die. Dr. Wyles explains they can accumulate with age and in chronic wounds, releasing signals that influence the surrounding tissue. Her team studies patient samples to map these cells in conditions such as diabetic foot ulcers, then uses those learnings to build more realistic printed models, including patient-specific versions.</p>



<p>Both guests discuss how bioprinted skin for routine clinical use will take time. Progress depends on carefully defining the most urgent clinical problems, proving performance and scaling manufacturing. Potential future applications discussed include improved wound patches for burns, chronic wounds and tissue-loss injuries, along with better ways to test treatments before they ever reach patients.</p>



<p>Listen to the latest episode of "<a href="https://careinfo.mayoclinic.org/tomorrows-cure-podcast?mc_id=global&amp;amp;utm_source=newsnetwork&amp;amp;utm_medium=l&amp;amp;utm_content=tcseasontwoepisodeeight&amp;amp;utm_campaign=mayoclinic&amp;amp;geo=global&amp;amp;placementsite=enterprise&amp;amp;invsrc=other&amp;amp;cauid=190207">Tomorrow's Cure</a>" wherever you get your podcasts. You can explore the full library of episodes and guests on the show's page.</p>



<p></p>



<p></p>



<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/tomorrows-cure-3d-bioprinting-living-human-skin-to-improve-wound-care-testing/">Tomorrow&amp;#8217;s Cure: 3D bioprinting living human skin to improve wound care,&nbsp;testing&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Skinspan-Bioprinting_Episode-Art_3000x3000.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/TC_Skinspan-Bioprinting_YT-Thumbnail_1280x720.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Saranya Wyles]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Tomorrow's Cure]]></mayoclinic:mctag>	</item>
		<item>
		<title>New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/new-ct-imaging-oral-contrast-agent-improves-visualization-of-bowel-anatomy-clinical-trial-data-show/</link>
		
		<dc:creator><![CDATA[Ethan Grove]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 19:24:51 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Minnesota]]></category>
		<category><![CDATA[News Releases]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Joel Fletcher]]></category>
		<category><![CDATA[Minnesota News Releases]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409666</guid>

					<description><![CDATA[<p>ROCHESTER, Minn. — In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the University of California San Francisco, and Nextrast Inc. found that a new imaging oral agent, also known as a "contrast agent," helps radiologists better see bowel structures and disease in CT imaging when compared [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/new-ct-imaging-oral-contrast-agent-improves-visualization-of-bowel-anatomy-clinical-trial-data-show/">New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/image-1024x683.png" alt="A technologist prepares a patient for a CT scan" class="wp-image-409648" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/image-1024x683.png 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/image-300x200.png 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/image-768x512.png 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/image-1536x1024.png 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/image.png 1687w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">A technologist prepares a patient for a CT scan.</figcaption></figure>



<p>ROCHESTER, Minn. — In a new <a href="https://link.springer.com/article/10.1007/s00261-025-05308-w" target="_blank" rel="noreferrer noopener">pilot feasibility study</a>, researchers from <a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>, the University of Washington School of Medicine, the University of California San Francisco, and Nextrast Inc. found that a new imaging oral agent, also known as a "contrast agent," helps radiologists better see bowel structures and disease in CT imaging when compared with the current oral contrast agents.</p>


<div class="wp-block-image">
<figure class="alignright size-medium"><img loading="lazy" decoding="async" width="300" height="200" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Fletcher_1577788_3776409_0013-300x200.jpg" alt="Portrait of Dr. Joel Fletcher" class="wp-image-409652" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Fletcher_1577788_3776409_0013-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Fletcher_1577788_3776409_0013-1024x682.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Fletcher_1577788_3776409_0013-768x512.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Fletcher_1577788_3776409_0013-1536x1024.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Fletcher_1577788_3776409_0013.jpg 1688w" sizes="auto, (max-width: 300px) 100vw, 300px" /><figcaption class="wp-element-caption">Joel Fletcher, M.D.</figcaption></figure>
</div>


<p>The introduction of a new oral contrast agent for CT imaging addresses common challenges in the diagnosis of bowel diseases, says by <a href="https://www.mayoclinic.org/biographies/fletcher-joel-g-m-d/bio-20053419" target="_blank" rel="noreferrer noopener">Joel Fletcher, M.D.</a>, lead author on the study and medical director of the <a href="https://www.mayo.edu/research/centers-programs/ct-clinical-innovation-center/overview" target="_blank" rel="noreferrer noopener">Mayo Clinic CT Clinical Innovation Center</a>. "The new oral contrast agent," he explains, "is ingested by patients prior to CT imaging and helps detect pathologies within and outside of the bowel wall in ways current imaging agents do not."</p>



<p>"We carefully designed this new class of oral contrast agent to overcome many of the diagnostic shortcomings of existing contrast agents for a broad range of diseases," says <a href="https://radiology.ucsf.edu/people/benjamin-yeh" target="_blank" rel="noreferrer noopener">Benjamin Yeh, M.D.</a>, a co-author on the study, radiologist at the University of California at San Francisco and co-founder of Nextrast, which created the new agent. "The Clinical Phase 2 results confirm that our dark agent can reveal previously impossible-to-detect findings, including very small bowel tumors and subtle inflammatory conditions that are often missed with conventional agents at CT."</p>



<p>In their <a href="https://link.springer.com/article/10.1007/s00261-025-05308-w" target="_blank" rel="noreferrer noopener">paper</a>, the authors report findings that suggest this new agent significantly improves visualization of inflammatory bowel disease (IBD) or cancer within the abdomen, and may provide earlier and more confident diagnoses.</p>



<p>The study compared CT scans of 32 patients with the dark borosilicate oral contrast agent and scans with conventional water or iodine-based oral contrast agents, to look at anatomical structures and disease presence.</p>



<p>"The novel dark borosilicate contrast agent has the potential to improve the assessment of numerous pathologies, including the detection of cancer and inflammatory disorders," says <a href="https://rad.uw.edu/people/amileto" target="_blank" rel="noreferrer noopener">Achille Mileto, M.D.</a>, a radiologist at the University of Washington School of Medicine and first author of the study.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/CT-Image-1024x576.jpg" alt="CT images from a patient who ingested the new oral solution that better distends the stomach (see the white S) and small bowel (asterisks) so that enhancing pathologies inside and outside the bowel wall can be better displayed and detected by radiologists." class="wp-image-409656" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/CT-Image-1024x576.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/CT-Image-300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/CT-Image-768x432.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/CT-Image.jpg 1360w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">CT images from a patient who ingested the new oral solution that better distends the stomach (see the white S) and small bowel (asterisks) so that enhancing pathologies inside and outside the bowel wall can be better displayed and detected by radiologists.</figcaption></figure>



<p>Evaluators identified clinically relevant findings in seven patients that were not detected using the standard contrast.</p>



<p>"CT scans performed with the new agent will likely do a better job of displaying pathologies in the stomach and proximal small bowel, areas where CT with traditional oral contrast performs poorly," Dr. Fletcher says. "Pathologies within the lumen will be better displayed because the lumen is more distended, and the brightness of the pathologies on the CT images will be increased, making them more conspicuous.”</p>



<p>The researchers say further study using a larger patient population is needed, but the initial findings show promise.</p>



<p>Review the <a href="https://link.springer.com/article/10.1007/s00261-025-05308-w" target="_blank" rel="noreferrer noopener">study</a> for a complete list of authors, disclosures and funding.</p>



<p>###</p>



<p><strong>About Mayo Clinic&amp;nbsp;<br></strong><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&amp;nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.&amp;nbsp;</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Ethan Grove, Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/new-ct-imaging-oral-contrast-agent-improves-visualization-of-bowel-anatomy-clinical-trial-data-show/">New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/image_1x1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/image_16x9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Joel Fletcher]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Minnesota News Releases]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[News Releases]]></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic researchers use AI to predict patient falls based on core density in middle age</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-use-ai-to-predict-patient-falls-based-on-core-density-in-middle-age/</link>
		
		<dc:creator><![CDATA[Vincent Jacobbi]]></dc:creator>
		<pubDate>Thu, 15 Jan 2026 14:00:00 +0000</pubDate>
				<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Minnesota]]></category>
		<category><![CDATA[News Releases]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Jennifer St. Sauver]]></category>
		<category><![CDATA[Minnesota News Releases]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409582</guid>

					<description><![CDATA[<p>ROCHESTER, Minn. — Artificial intelligence (AI) applied to abdominal imaging can help predict adults at higher risk of falling as early as middle age, a new Mayo Clinic study shows. The research, published in Mayo Clinic Proceedings: Digital Health, highlights the importance of abdominal muscle quality, a component of core strength, as a key predictor [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-use-ai-to-predict-patient-falls-based-on-core-density-in-middle-age/">Mayo Clinic researchers use AI to predict patient falls based on core density in middle age</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="800" height="533" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/GettyImages-1390882860.jpg" alt="" class="wp-image-409584" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/GettyImages-1390882860.jpg 800w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/GettyImages-1390882860-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/GettyImages-1390882860-768x512.jpg 768w" sizes="auto, (max-width: 800px) 100vw, 800px" /></figure>



<p>ROCHESTER, Minn. — Artificial intelligence (AI) applied to abdominal imaging can help predict adults at higher risk of falling as early as middle age, a new <a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> study shows. The research, published in <a href="https://www.sciencedirect.com/science/article/pii/S2949761225001063" target="_blank" rel="noreferrer noopener">Mayo Clinic Proceedings: Digital Health</a>, highlights the importance of abdominal muscle quality, a component of core strength, as a key predictor of fall risk in adults aged 45 years and older.</p>



<p>Falls are a leading cause of injury, especially among older adults. Mayo Clinic researchers found that early markers of fall risk may be detectable in <a href="https://www.mayoclinic.org/tests-procedures/ct-scan/about/pac-20393675" target="_blank" rel="noreferrer noopener">CT scans</a> that many patients have for other reasons.</p>



<p>Working with radiology bioinformatics experts, they set out to determine whether AI-derived measurements of fat distribution, muscle size and density and bone quality could reveal early signs of noteworthy physical changes.</p>



<p>They found that muscle density, a measure of muscle quality, was a much stronger predictor of fall risk than muscle size.</p>



<p>"Muscle size is just a measure of how big your muscles are," says lead author <a href="https://www.mayo.edu/research/faculty/st-sauver-jennifer-ph-d/bio-00027743" target="_blank" rel="noreferrer noopener">Jennifer St. Sauver, Ph.D.</a>, an epidemiologist at <a href="https://www.mayoclinic.org/patient-visitor-guide/minnesota" target="_blank" rel="noreferrer noopener">Mayo Clinic in Rochester</a>. "Muscle density is different; on a CT scan, it's a measure of how 'dark' and homogenous the muscles are."</p>



<p>More homogenous muscles are denser and tend to have less fat in them, Dr. St. Sauver notes.</p>



<p>"Previous studies have suggested that muscle density, not size, is more strongly associated with physical strength and function," she says. "Our results support the idea that we should be focusing on muscle density, not muscle size, when we try to understand physical function."</p>



<p>The research team expected to see links between poorer performance on abdominal muscle measures and a higher incidence of falls in older adults, but what surprised them most was the strength of these associations in middle-aged adults and how strongly those measures predicted fall risk.</p>



<p>"Leg muscles have been associated with physical function, but our findings show that abdominal muscles also play a significant role," Dr. St. Sauver says.</p>



<p>The findings underscore the importance of maintaining good core strength throughout adulthood, she adds.</p>



<p>"One of the most important messages from this research is to keep your abdominal muscles in the best shape possible," Dr. St Sauver says. "Doing so may provide benefits that start in midlife and continue well into older adulthood."</p>



<p>For tips on improving your abdominal core strength, visit <a href="https://www.mayoclinic.org/healthy-lifestyle/fitness/in-depth/core-strength/art-20546851" target="_blank" rel="noreferrer noopener">mayoclinic.org</a>.</p>



<p>###&amp;nbsp;</p>



<p><strong>About Mayo Clinic</strong> <br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&amp;nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Vincent Jacobbi, Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-use-ai-to-predict-patient-falls-based-on-core-density-in-middle-age/">Mayo Clinic researchers use AI to predict patient falls based on core density in middle age</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/A-woman-practices-yoga-on-a-mat-outdoors-in-a-park_GettyImages-1390882860_1x1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/A-woman-practices-yoga-on-a-mat-outdoors-in-a-park_GettyImages-1390882860_16x9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Jennifer St. Sauver]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Minnesota News Releases]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[News Releases]]></mayoclinic:mctag>	</item>
		<item>
		<title>Families at Mayo Clinic explore how a smartwatch can give early warnings of severe tantrums&nbsp;</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/families-at-mayo-clinic-explore-how-a-smartwatch-can-give-early-warnings-of-severe-tantrums/</link>
		
		<dc:creator><![CDATA[Susan Murphy]]></dc:creator>
		<pubDate>Wed, 14 Jan 2026 10:00:00 +0000</pubDate>
				<category><![CDATA[AI and Digital Health]]></category>
		<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Individualized Medicine]]></category>
		<category><![CDATA[Pediatrics Patient Stories]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Research Patient Stories]]></category>
		<category><![CDATA[Sharing Mayo Clinic]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Arjun Athreya]]></category>
		<category><![CDATA[Dr. Julia Shekunov]]></category>
		<category><![CDATA[Dr. Magdalena Romanowicz]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409524</guid>

					<description><![CDATA[<p>Evenings in the Staal household often carried a delicate unpredictability. After a full school day — and as Ethan's medication began to wear off — the shift from playful to overwhelmed could happen in seconds. Ethan has attention-deficit/hyperactivity disorder (ADHD), a condition that can make emotional regulation especially challenging.&amp;#160;&amp;#160; Ethan's feelings sometimes escalated faster than [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/families-at-mayo-clinic-explore-how-a-smartwatch-can-give-early-warnings-of-severe-tantrums/">Families at Mayo Clinic explore how a smartwatch can give early warnings of severe tantrums&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Ethan-3-1024x576.png" alt="" class="wp-image-409525" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Ethan-3-1024x576.png 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Ethan-3-300x169.png 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Ethan-3-768x432.png 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Ethan-3-1536x864.png 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Ethan-3.png 1920w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Ethan Staal poses for a photo on the first day of school, wearing the smartwatch used in a Mayo Clinic research study. <em>Photo provided by the Staal family.</em></figcaption></figure>



<div style="height:10px" aria-hidden="true" class="wp-block-spacer"></div>



<p>Evenings in the Staal household often carried a delicate unpredictability. After a full school day — and as Ethan's medication began to wear off — the shift from playful to overwhelmed could happen in seconds. Ethan has <a href="https://www.mayoclinic.org/diseases-conditions/adhd/symptoms-causes/syc-20350889" target="_blank" rel="noreferrer noopener">attention-deficit/hyperactivity disorder (ADHD)</a>, a condition that can make emotional regulation especially challenging.&amp;nbsp;&amp;nbsp;</p>



<p>Ethan's feelings sometimes escalated faster than he could manage. In those difficult moments, his parents say, he became "not accessible"&amp;nbsp;—&amp;nbsp;often needing close to an hour before they could help guide him back to calm.&amp;nbsp;</p>


<div class="wp-block-image">
<figure class="alignright size-large is-resized"><img loading="lazy" decoding="async" width="684" height="1024" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Henning66-684x1024.jpg" alt="" class="wp-image-409537" style="width:327px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Henning66-684x1024.jpg 684w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Henning66-200x300.jpg 200w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Henning66-768x1150.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Henning66-1025x1536.jpg 1025w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Henning66-1367x2048.jpg 1367w" sizes="auto, (max-width: 684px) 100vw, 684px" /><figcaption class="wp-element-caption">The Staal family. <em>Photo provided by the Staal family.</em></figcaption></figure>
</div>


<p>Their search for specialized care led them to&amp;nbsp;<a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo&amp;nbsp;Clinic</a>, where child and adolescent psychiatrist&amp;nbsp;<a href="https://www.mayoclinic.org/biographies/romanowicz-magdalena-m-d/bio-20306747" target="_blank" rel="noreferrer noopener">Magdalena Romanowicz, M.D.</a>, introduced the family to Parent-Child Interaction Therapy. She also invited them to&amp;nbsp;participate&amp;nbsp;in a first-of-its-kind study powered by a smartwatch and artificial intelligence (AI).&amp;nbsp;</p>



<p>The smartwatch technology was designed to help anticipate when a child was nearing emotional overload, giving parents a chance to step in and defuse the situation before it escalated. For the Staals, the technology offered a clear sense of what was happening inside Ethan just early enough to help him through it.&amp;nbsp;</p>



<p>"It was a game-changer," Jared Staal says. "We still have challenges, but now we see them coming and we see them through a whole different lens — we didn't always know how to support him in those moments, and now we do."&amp;nbsp;</p>



<h2 class="wp-block-heading"><strong>A window into the moments before escalation</strong></h2>



<p>During the four-month <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842819" target="_blank" rel="noreferrer noopener">study</a>, Ethan wore a smartwatch that tracked his heart rate, movement and sleep. When the system detected patterns that suggested his stress was building, it sent an alert to Sarah or Jared's phone.&amp;nbsp;</p>



<p>"It gave us a warning that something was coming," Sarah says. Instead of reacting at the peak of Ethan's distress, they could intervene earlier with calm reassurance, redirection and other techniques they learned in their 12 Parent-Child Interaction Therapy&nbsp;sessions.&nbsp;</p>



<p>"We could help him recover in 5 to 10 minutes," she says. "And we could have our evenings again as a family."&amp;nbsp;</p>



<h2 class="wp-block-heading"><strong>What the study revealed</strong>&amp;nbsp;</h2>



<p>The Staals' experience reflects the study's overall findings.&amp;nbsp;In the clinical trial, smartwatch alerts prompted parents to respond within four seconds on average to early signs of escalating stress. Their children's severe tantrums were shortened by about 11 minutes — roughly half the duration seen with standard therapy alone.&amp;nbsp;</p>



<p>The broader context underscores the need for new approaches. Nearly 1 in 5 U.S. children lives with a mental, behavioral or emotional health disorder, yet the number of pediatric mental health specialists has not kept pace with demand. Smartwatch technology represents one possible way to extend support into the home by helping families recognize early changes in a child's stress levels.&amp;nbsp;</p>



<h2 class="wp-block-heading"><strong>Across a shared wall</strong>&amp;nbsp;</h2>


<div class="wp-block-image">
<figure class="aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="683" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/ARJUN-ATHREYA-resize-1024x683.jpg" alt="" class="wp-image-409538" style="aspect-ratio:1.499330655957162;width:706px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/ARJUN-ATHREYA-resize-1024x683.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/ARJUN-ATHREYA-resize-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/ARJUN-ATHREYA-resize-768x512.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/ARJUN-ATHREYA-resize-1536x1024.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/ARJUN-ATHREYA-resize-2048x1365.jpg 2048w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Dr. Arjun Athreya</figcaption></figure>
</div>


<p>The technology behind the alerts emerged from an unexpected spark.&amp;nbsp;</p>



<p>Electrical and computer engineer <a href="https://www.mayo.edu/research/faculty/athreya-arjun-p-ph-d-m-s/bio-20473903" target="_blank" rel="noreferrer noopener">Arjun Athreya, Ph.D.</a>, worked just steps from the Children's Hospital Psychiatry Unit at Mayo Clinic — a single shared wall separating his world of algorithms and data from the clinical rooms where children and their families experienced some of their hardest moments.&amp;nbsp;&amp;nbsp;</p>



<p>Passing conversations with the psychiatrists next door became more formal collaborations as the team began to ask: What happens inside a child's body in the minutes before an outburst? And could those invisible shifts be measured?&amp;nbsp;</p>



<p>With support from <a href="https://www.mayoclinic.org/biographies/shekunov-julia-m-d/bio-20359665" target="_blank" rel="noreferrer noopener">Julia&amp;nbsp;Shekunov, M.D.</a>, Medical Director of the inpatient unit, and help from the nursing staff, the team launched a small pilot to explore those questions.&amp;nbsp;<br>&amp;nbsp;<br>From that work, Dr. Athreya and his team developed an AI model designed to recognize the earliest physiological changes that precede escalating behavior. That work became the&amp;nbsp;foundation&amp;nbsp;for&amp;nbsp;the smartwatch system now being explored with families.&amp;nbsp;</p>



<h2 class="wp-block-heading"><strong>A family's early role in the research</strong>&amp;nbsp;</h2>


<div class="wp-block-image">
<figure class="aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Theo2-1024x576.png" alt="" class="wp-image-409531" style="width:723px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Theo2-1024x576.png 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Theo2-300x169.png 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Theo2-768x432.png 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Theo2-1536x864.png 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Theo2.png 1920w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Theo Maurer plays with LEGOs. <em>Photo provided by the Maurer family.</em></figcaption></figure>
</div>


<div style="height:10px" aria-hidden="true" class="wp-block-spacer"></div>



<p>One of the first families to try out the smartwatch system was Sawra&amp;nbsp;and Matthew&amp;nbsp;Maurer and&amp;nbsp;their&amp;nbsp;son, Theo.&amp;nbsp;&amp;nbsp;</p>



<p>For&amp;nbsp;the&amp;nbsp;Maurers, the challenges with Theo were mounting. Calls from kindergarten&amp;nbsp;had&amp;nbsp;become a near-weekly routine: "Theo is having a hard time. Could you&amp;nbsp;come get&amp;nbsp;him?"&amp;nbsp;Around that same time, Theo was diagnosed with ADHD, which helped explain the emotional dysregulation and sudden behavioral shifts they were seeing.&amp;nbsp;&amp;nbsp;</p>



<p>Theo could slide from being engaged in an activity to overwhelmed in an instant — sweeping crayons off tables or having severe tantrums that&amp;nbsp;sometimes required&amp;nbsp;teachers to guide classmates out of the room. "It was a very difficult year," Sawra recalls.&amp;nbsp;</p>


<div class="wp-block-image">
<figure class="alignright size-large is-resized"><img loading="lazy" decoding="async" width="768" height="1024" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Theo3-768x1024.jpg" alt="" class="wp-image-409543" style="aspect-ratio:0.7500062070164113;width:332px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Theo3-768x1024.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Theo3-225x300.jpg 225w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Theo3-1152x1536.jpg 1152w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Theo3-1536x2048.jpg 1536w" sizes="auto, (max-width: 768px) 100vw, 768px" /><figcaption class="wp-element-caption">Theo Maurer poses for a first-day-of-school photo. <em>Photo provided by the Maurer family.</em></figcaption></figure>
</div>


<p>Enrolling in the early smartwatch <a href="https://pubmed.ncbi.nlm.nih.gov/37966360/" target="_blank" rel="noreferrer noopener">feasibility study</a> gave her new insight.&amp;nbsp;&amp;nbsp;</p>



<p>During the study, Theo wore a watch each day that collected his physiological data — heart rate, movement, sleep patterns — while the family logged episodes in an AI-powered app.&amp;nbsp;</p>



<p>That data helped researchers understand what Theo's body was doing in the moments before he became dysregulated. By matching those physiological signals with what was happening behaviorally, the team could begin identifying the subtle shifts that happen as a child moves from calm toward distress and then back to calm.&amp;nbsp;</p>



<p>Theo's data helped teach the system what those early changes look like in real-world settings.&amp;nbsp;</p>



<p>Sawra didn't receive alerts in that early phase, but she could see the information the watch recorded. "The idea is wonderful," she says. "Being able to detect when a child is heading toward a severe tantrum would be a phenomenal thing for a parent."&amp;nbsp;</p>



<h2 class="wp-block-heading"><strong>Moving the research forward</strong></h2>



<p>Future studies will focus on improving the model, testing the system in larger groups and examining how real-time physiological data can inform care outside the clinic. As that work continues, the experiences of families like the Staals and the Maurers will help guide how the technology evolves and how it can support children in everyday life.&amp;nbsp;</p>



<h2 class="wp-block-heading"><strong>Related article</strong></h2>



<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow">
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="1920" height="1080" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/12/16x9-TANTRUMS.png" alt="" class="wp-image-408857" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/12/16x9-TANTRUMS.png 1920w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/12/16x9-TANTRUMS-300x169.png 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/12/16x9-TANTRUMS-1024x576.png 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/12/16x9-TANTRUMS-768x432.png 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/12/16x9-TANTRUMS-1536x864.png 1536w" sizes="auto, (max-width: 1920px) 100vw, 1920px" /></figure>
</div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow">
<p><strong><a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-smartwatch-system-helps-parents-shorten-and-defuse-childrens-severe-tantrums-early/" target="_blank" rel="noreferrer noopener">Mayo Clinic smartwatch system helps parents shorten, defuse children’s severe tantrums early</a></strong></p>



<p>Mayo Clinic&amp;nbsp;researchers have developed a smartwatch-based alert system that signals parents at the earliest signs of a tantrum in children with emotional and behavioral disorders — prompting them to intervene before it intensifies.&amp;nbsp;<a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-smartwatch-system-helps-parents-shorten-and-defuse-childrens-severe-tantrums-early/" target="_blank" rel="noreferrer noopener">Read more.</a></p>



<p></p>
</div>
</div>



<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/families-at-mayo-clinic-explore-how-a-smartwatch-can-give-early-warnings-of-severe-tantrums/">Families at Mayo Clinic explore how a smartwatch can give early warnings of severe tantrums&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/1x1ethan.png</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/16x9-Ethan-3.png</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Arjun Athreya]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Julia Shekunov]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Magdalena Romanowicz]]></mayoclinic:mctag>	</item>
		<item>
		<title>New Mayo Clinic study advances personalized prostate cancer education with an EHR-integrated AI agent&nbsp;</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/new-mayo-clinic-study-advances-personalized-prostate-cancer-education-with-an-ehr-integrated-ai-agent/</link>
		
		<dc:creator><![CDATA[rebeccabromelkamp]]></dc:creator>
		<pubDate>Wed, 07 Jan 2026 17:45:18 +0000</pubDate>
				<category><![CDATA[AI and Digital Health]]></category>
		<category><![CDATA[Arizona]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Featured News]]></category>
		<category><![CDATA[Medical Innovation]]></category>
		<category><![CDATA[News Releases]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[#Newsapp]]></category>
		<category><![CDATA[Arizona News Releases]]></category>
		<category><![CDATA[daily]]></category>
		<category><![CDATA[Dr. Wei Liu]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<guid isPermaLink="false">https://newsnetwork.mayoclinic.org/?p=409383</guid>

					<description><![CDATA[<p>PHOENIX&amp;#160;—&amp;#160;Mayo Clinic&amp;#160;researchers have developed and evaluated MedEduChat, an electronic health record (EHR)&amp;#160;that&amp;#160;works with&amp;#160;a&amp;#160;large language model to provide accurate, patient-specific prostate cancer education.&amp;#160;&amp;#160; The findings are published in&amp;#160;Nature Portfolio Digital Medicine&amp;#160;and highlight&amp;#160;a new approach&amp;#160;to delivering&amp;#160;timely, individualized guidance for people navigating a prostate cancer diagnosis.&amp;#160;&amp;#160; Cancer patients often face uncertainty as they process complex information about their [&amp;#8230;]</p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/new-mayo-clinic-study-advances-personalized-prostate-cancer-education-with-an-ehr-integrated-ai-agent/">New Mayo Clinic study advances personalized prostate cancer education with an EHR-integrated AI agent&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Man-using-computer-tablet-shutterstock_151335656-16x9--1024x576.jpg" alt="Man smiling, using computer tablet" class="wp-image-409385" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Man-using-computer-tablet-shutterstock_151335656-16x9--1024x576.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Man-using-computer-tablet-shutterstock_151335656-16x9--300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Man-using-computer-tablet-shutterstock_151335656-16x9--768x432.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Man-using-computer-tablet-shutterstock_151335656-16x9--1536x864.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Man-using-computer-tablet-shutterstock_151335656-16x9-.jpg 1604w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></figure>



<p>PHOENIX&amp;nbsp;—&amp;nbsp;<a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&amp;nbsp;researchers have developed and evaluated MedEduChat, an electronic health record (EHR)&amp;nbsp;that&amp;nbsp;works with&amp;nbsp;a&amp;nbsp;large language model to provide accurate, patient-specific <a href="https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087" target="_blank" rel="noreferrer noopener">prostate cancer</a> education.&amp;nbsp;&amp;nbsp;</p>



<p>The findings are published in&amp;nbsp;<a href="https://www.nature.com/articles/s41746-025-02166-0" target="_blank" rel="noreferrer noopener">Nature Portfolio Digital Medicine</a>&amp;nbsp;and highlight&amp;nbsp;a new approach&amp;nbsp;to delivering&amp;nbsp;timely, individualized guidance for people navigating a prostate cancer diagnosis.&amp;nbsp;&amp;nbsp;</p>



<p>Cancer patients often face uncertainty as they process complex information about their diagnosis and treatment options. Limited time with clinicians can make it difficult for patients to receive the detailed answers they need to understand decisions that shape their care.&amp;nbsp;&amp;nbsp;</p>



<p>This&amp;nbsp;MedEduChat&amp;nbsp;study&amp;nbsp;demonstrates&amp;nbsp;how advanced AI, grounded in Mayo-validated clinical data, can help bridge these gaps by delivering clear, conversational explanations based on each patient's own health record.&amp;nbsp;&amp;nbsp;</p>



<h2 class="wp-block-heading"><strong>Understanding the patient experience using&amp;nbsp;AI</strong>&amp;nbsp;</h2>



<p>Fifteen prostate cancer patients interacted with&amp;nbsp;MedEduChat&amp;nbsp;for 20 to 30 minutes as part of a mixed-method usability study conducted at Mayo Clinic campuses in Arizona and Minnesota.&amp;nbsp;</p>



<p>Patients reported higher confidence after using the tool, with Health Confidence Scores increasing from 9.9 to 13.9 on a 16-point scale. Usability scores were also high;&amp;nbsp;average survey responses ranked MedEduChat&amp;nbsp;83.7 out of 100.&amp;nbsp;&amp;nbsp;</p>



<p>Patients noted that&amp;nbsp;MedEduChat&amp;nbsp;helped them understand their diagnosis in a more accessible way. The&amp;nbsp;tool&amp;nbsp;provided relief by explaining unfamiliar or complex terms&amp;nbsp;in a clear and concise manner.&amp;nbsp;&amp;nbsp;</p>



<p>The conversational format&amp;nbsp;helped&amp;nbsp;participants replace incorrect assumptions with medically accurate information derived from their own EHR.&amp;nbsp;&amp;nbsp;</p>



<h2 class="wp-block-heading"><strong>Clinician-evaluated accuracy and safety</strong>&amp;nbsp;</h2>



<p><a href="https://www.mayoclinic.org/biographies/liu-wei-ph-d/bio-20055721" target="_blank" rel="noreferrer noopener">Wei Liu, Ph.D.</a>,&amp;nbsp;a radiation oncology medical physicist,&amp;nbsp;and three Mayo Clinic clinicians independently reviewed 85 anonymized question-and-response pairs. They rated MedEduChat's answers as highly correct (2.9 out of 3), complete (2.7 out of 3) and safe (2.7 out of 3).&amp;nbsp;</p>



<p>Clinicians also noted strong patient-readiness and moderate personalization, reflecting&amp;nbsp;MedEduChat's ability to tailor explanations to each person's age, treatment history and cancer stage.&amp;nbsp;&amp;nbsp;</p>



<p>Although&amp;nbsp;MedEduChat&amp;nbsp;delivered&amp;nbsp;accurate&amp;nbsp;and clinically aligned information, clinicians emphasized the importance of ongoing monitoring to prevent errors that could arise from incomplete or inconsistently documented EHR data.</p>



<p>The research team incorporated a&amp;nbsp;multilayer&amp;nbsp;approach&amp;nbsp;to address these concerns and guide future system enhancements.</p>



<h2 class="wp-block-heading"><strong>Combining patient-centered education with AI</strong>&amp;nbsp;</h2>



<p>MedEduChat&amp;nbsp;was designed with a structured educational model that combines closed-domain clinical data, semi-structured guidance and personalized interaction.</p>



<p>Patients can explore diagnosis details, learn about treatment options and side effects, and review lifestyle considerations and follow-up expectations. The tool draws only from validated sources,&amp;nbsp;such as Mayo Clinic materials and&amp;nbsp;<a href="https://www.nccn.org/" target="_blank" rel="noreferrer noopener">National Comprehensive Cancer Network</a>&amp;nbsp;guidelines.</p>



<p>"This research demonstrates how large language models can be safely and effectively integrated into real clinical systems to improve cancer education,"&amp;nbsp;according&amp;nbsp;to Dr. Liu.&amp;nbsp;"By combining advanced AI with Mayo Clinic's electronic health records, MedEduChat delivers personalized, accurate and easy-to-understand explanations tailored to each patient's medical history."</p>



<h2 class="wp-block-heading"><strong>Expanding AI&amp;nbsp;cancer research</strong>&amp;nbsp;</h2>



<p>The study team plans to translate this work into clinical use across all three Mayo Clinic campuses&amp;nbsp;in Arizona,&amp;nbsp;Florida&amp;nbsp;and Minnesota. Next steps include expanding MedEduChat beyond radiation oncology to additional cancer specialties. These efforts aim to make personalized AI-assisted education a routine part of cancer care.</p>



<p>This research was funded by the National Cancer Institute, the Eric and Wendy Schmidt Fund for AI Research and Innovation, the Fred C. and Katherine B. Andersen Foundation, and The Kemper and Ethel Marley Fund in Cancer Research.</p>



<p>###&amp;nbsp;</p>



<p><strong>About Mayo Clinic Comprehensive Cancer Center</strong>&amp;nbsp;<br>Designated as a comprehensive cancer center by the&amp;nbsp;<a href="https://www.cancer.gov/" target="_blank" rel="noreferrer noopener">National Cancer Institute</a>,&amp;nbsp;<a href="https://www.mayoclinic.org/departments-centers/mayo-clinic-cancer-center" target="_blank" rel="noreferrer noopener">Mayo Clinic Comprehensive Cancer Center</a>&amp;nbsp;is defining the cancer center of the future, focused on delivering the world's most exceptional patient-centered cancer care for everyone. At Mayo Clinic Comprehensive Cancer Center, a culture of innovation and collaboration is driving research breakthroughs in cancer detection,&amp;nbsp;prevention&amp;nbsp;and treatment to change lives.&amp;nbsp;&amp;nbsp;</p>



<p><strong>About Mayo&amp;nbsp;Clinic</strong>&amp;nbsp;<br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&amp;nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion,&amp;nbsp;expertise&amp;nbsp;and answers to everyone who needs healing. Visit the&amp;nbsp;<a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a>&amp;nbsp;for&amp;nbsp;additional&amp;nbsp;Mayo Clinic news.&amp;nbsp;</p>



<p><strong>Media contact:</strong>&amp;nbsp;</p>



<ul class="wp-block-list">
<li>Julie Ferris-Tillman, Ph.D., Mayo Clinic Communications,&amp;nbsp;<a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/new-mayo-clinic-study-advances-personalized-prostate-cancer-education-with-an-ehr-integrated-ai-agent/">New Mayo Clinic study advances personalized prostate cancer education with an EHR-integrated AI agent&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Man-using-computer-tablet-shutterstock_151335656.-1x1-1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2026/01/Man-using-computer-tablet-shutterstock_151335656-16x9-.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><![CDATA[#Newsapp]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Arizona News Releases]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[daily]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Dr. Wei Liu]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[News Releases]]></mayoclinic:mctag><mayoclinic:mctag><![CDATA[Prostate Cancer]]></mayoclinic:mctag>	</item>
	</channel>
</rss> 